InvestSMART

The Hydration Pharmaceuticals Company Limited (ASX: HPC) - Announcements

- Current share price for HPC : $0.004

ASX company news and announcements for The Hydration Pharmaceuticals Company Limited (HPC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All The Hydration Pharmaceuticals Company Limited (HPC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than The Hydration Pharmaceuticals Company Limited (HPC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for The Hydration Pharmaceuticals Company Limited (HPC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2 Appendix 4E and Annual Report 27 Feb 2026 3:27PM $0.005 $0.004 fallen by 20%
$2 Cost savings implemented & inventory replenishment completed 17 Feb 2026 9:50AM $0.005 $0.004 fallen by 20%
$2 Q4 FY25 Quarterly Activities Report (App 4C) 30 Jan 2026 4:06PM $0.005 $0.004 fallen by 20%
$2 Change of Directors Interest Notices 7 Jan 2026 1:24PM $0.005 $0.004 fallen by 20%
$2 Notification of cessation of securities - HPC 7 Jan 2026 12:10PM $0.005 $0.004 fallen by 20%
$2 Q3 FY25 Quarterly Activities Report (App 4C) 31 Oct 2025 8:47AM $0.007 $0.004 fallen by 42.86%
$2 Notice of ceasing to be a substantial holder 8 Oct 2025 8:25PM $0.009 $0.004 fallen by 55.56%
$2 Notice of ceasing to be a substantial holder 7 Oct 2025 11:20AM $0.010 $0.004 fallen by 60%
$2 Notification of cessation of securities - HPC 6 Oct 2025 3:42PM $0.011 $0.004 fallen by 63.64%
$2 Q3 CY25 Sales Update and Product Launch 3 Oct 2025 9:32AM $0.008 $0.004 fallen by 50%
$2 Appendix 4D and FY25 Half Year Financial Report 29 Aug 2025 11:14AM $0.011 $0.004 fallen by 63.64%
$2 Appendix 4D and FY25 Half Year Financial Report 29 Aug 2025 11:14AM $0.011 $0.004 fallen by 63.64%
$2 Hydralyte Plus Metabolic Support product launched 12 Aug 2025 9:04AM $0.010 $0.004 fallen by 60%
$2 Q2 FY25 Quarterly Activities Report (App 4C) 31 Jul 2025 10:33AM $0.014 $0.004 fallen by 71.43%
$2 Notice of initial substantial holder 16 Jul 2025 4:44PM $0.010 $0.004 fallen by 60%
$2 Notice of initial substantial holder 14 Jul 2025 4:04PM $0.011 $0.004 fallen by 63.64%
$2 Change in substantial holding 10 Jul 2025 4:59PM $0.011 $0.004 fallen by 63.64%
$2 Final Placement of Shortfall Shares 10 Jul 2025 11:41AM $0.012 $0.004 fallen by 66.67%
$2 Application for quotation of securities - HPC 10 Jul 2025 11:38AM $0.012 $0.004 fallen by 66.67%
$2 Placement of Shortfall Shares 8 Jul 2025 10:44AM $0.013 $0.004 fallen by 69.23%
$2 Application for quotation of securities - HPC 8 Jul 2025 10:38AM $0.013 $0.004 fallen by 69.23%
$2 Notification of cessation of securities - HPC 4 Jul 2025 5:40PM $0.011 $0.004 fallen by 63.64%
$2 Cleansing Notice 30 Jun 2025 2:19PM $0.011 $0.004 fallen by 63.64%
$2 Application for quotation of securities - HPC 30 Jun 2025 2:15PM $0.011 $0.004 fallen by 63.64%
$2 Trading Update 19 Jun 2025 9:49AM $0.010 $0.004 fallen by 60%

26 - 50 of 280 results

Page 2 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.